TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3027% below fair value
$96.43+2.52 (+2.68%)
Close on Nov 18, 2026Market cap $3.34BP/E 25.0Yield 0.00%
TransMedics net income
Net income is the profit left for shareholders after every expense, interest and tax.
TransMedics's net income for the twelve months ending Jun 30, 2026 was $151.70M, up 111.7% year over year. For fiscal 2025 it was $190.29M, up 436.6% from the year before. The highest annual figure on record is $190.29M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $190.29M | +436.6% |
| FY2024 | Dec 31, 2024 | $35.46M | – |
| FY2023 | Dec 31, 2023 | -$25.03M | – |
| FY2022 | Dec 31, 2022 | -$36.23M | – |
| FY2021 | Dec 31, 2021 | -$44.22M | – |
| FY2020 | Dec 31, 2020 | -$28.75M | – |
| FY2019 | Dec 28, 2019 | -$33.55M | – |
| FY2018 | Dec 29, 2018 | -$23.76M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $14.68M | -57.9% |
| Q1 FY2026 | Mar 31, 2026 | $7.32M | -71.5% |
| Q4 FY2025 | Dec 31, 2025 | $105.38M | +1436.9% |
| Q3 FY2025 | Sep 30, 2025 | $24.32M | +476.8% |
| Q2 FY2025 | Jun 30, 2025 | $34.91M | +186.3% |
| Q1 FY2025 | Mar 31, 2025 | $25.68M | +110.6% |
| Q4 FY2024 | Dec 31, 2024 | $6.86M | +70.1% |
| Q3 FY2024 | Sep 30, 2024 | $4.22M | – |
| Q2 FY2024 | Jun 30, 2024 | $12.19M | – |
| Q1 FY2024 | Mar 31, 2024 | $12.20M | – |
| Q4 FY2023 | Dec 31, 2023 | $4.03M | – |
| Q3 FY2023 | Sep 30, 2023 | -$25.42M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.00M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.64M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.72M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.43M | – |
| Q2 FY2022 | Jun 30, 2022 | -$11.52M | – |
| Q1 FY2022 | Mar 31, 2022 | -$10.56M | – |
| Q4 FY2021 | Dec 31, 2021 | -$12.67M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.96M | – |
| Q2 FY2021 | Jun 30, 2021 | -$10.67M | – |
| Q1 FY2021 | Mar 31, 2021 | -$7.92M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.31M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.09M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.50M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.85M | – |
| Q4 FY2019 | Dec 28, 2019 | -$9.18M | – |
| Q3 FY2019 | Sep 28, 2019 | -$8.28M | – |
| Q2 FY2019 | Jun 29, 2019 | -$9.20M | – |
| Q1 FY2019 | Mar 30, 2019 | -$6.90M | – |
| Q4 FY2018 | Dec 29, 2018 | -$7.64M | – |
| Q3 FY2018 | Sep 29, 2018 | -$5.11M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.12M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.90M | – |
See a number that looks wrong?